Noom Med vs Ro 2026: Costs, Medications and Coaching Compared
Noom Med vs Ro 2026: Costs, Medications and Coaching Compared
Quick answer
Related: Ro pricing guide, cheapest legal GLP-1 online cornerstone.
The third option: Individual results vary.
Start your online visitWritten by Trimi Medical Team. Medically reviewed by Dr. Sean Arora, MD. This comparison is updated regularly when pricing, medication availability, or provider policies change across Noom Med, Ro, and other GLP-1 platforms.
Quick links: Semaglutide treatment, tirzepatide treatment, and cheapest GLP-1 injections 2026.
More on GLP-1 Provider Comparisons
Noom Med vs Ro for Weight Loss: What You Need to Know
Related: semaglutide, tirzepatide, is Noom Med legit.
Definition
Noom Med is the prescription medication arm of the Noom weight loss platform, combining GLP-1 drugs like semaglutide with Noom's app-based behavioral coaching program. Ro (formerly Roman) is a direct-to-consumer telehealth company offering GLP-1 medications through its Body program as part of a broader health platform that also covers sexual health, dermatology, and other conditions.
Noom Med vs Ro vs Trimi: Side-by-Side Comparison
Related: GLP-1 weight loss program.
| Feature | Noom Med | Ro | Trimi |
|---|---|---|---|
| Contract commitment | Varies by plan | Prepaid 3-, 6- and 12-month options (March 2026 announcement) | Annual plan (12-mo) |
| Other health services | Noom app ecosystem | Sexual health, derm, hair loss | GLP-1 focused |
Related: Ro pricing guide.
Pricing Breakdown: The Real Cost of Each Provider
Understanding the true cost of GLP-1 therapy through each provider requires looking beyond the headline monthly price.
Noom Med Pricing
Related: semaglutide.
Before enrolling, confirm exactly what is and is not included in the quoted price.
Ro Pricing
Related: Ro pricing guide, how Ro works for weight loss.
Trimi Pricing
Related: Trimi.
Related information
Related: cheapest legal GLP-1 online cornerstone.
The Coaching Debate: Is Noom's Behavioral Program Worth the Premium?
However, there are important counterpoints. First, Noom's coaching is primarily algorithm-driven and delivered through an app rather than through one-on-one sessions with a clinical psychologist or certified obesity specialist. The level of personalization and clinical depth is not comparable to formal behavioral therapy conducted by a specialist. Second, GLP-1 medications themselves fundamentally alter the behavioral equation by reducing appetite, decreasing food noise, and making it physiologically easier to eat less, which means the behavioral challenges that coaching addresses are already significantly mitigated by the medication. Third, many patients report declining engagement with the Noom app over time while continuing to pay the subscription fee.
Related: managing side effects.
Ro's Approach: Medication-Focused Telehealth
Ro (originally launched as Roman for men's health) has evolved into one of the largest direct-to-consumer telehealth platforms in the United States. Unlike Noom, which started as a behavioral weight loss app, Ro built its business around convenient, affordable access to prescription medications across multiple health categories. The weight loss program, Ro Body, is one vertical within a broader platform that also covers sexual health, dermatology, hair loss, and other conditions.
Related: side effect management.
Ro's current pricing page describes on-demand provider support, including help with side effects and dose adjustments. Confirm the current coaching and lifestyle-support options before deciding whether the program meets your needs.
Clinical Evidence: What the Research Shows
The clinical evidence supporting GLP-1 medications for weight loss is robust, and it comes from trials of the FDA-approved brand-name products, not compounded preparations.
Semaglutide: STEP Trial Program
The landmark STEP 1 trial enrolled 1,961 adults with obesity or overweight with at least one weight-related comorbidity and randomized them to semaglutide 2.4 mg weekly or placebo, both with lifestyle counseling. At 68 weeks, the semaglutide group lost an average of 14.9% of body weight compared to 2.4% in the placebo group (Wilding et al., New England Journal of Medicine, 2021).
Related: side effect profiles, semaglutide, tirzepatide.
Noom Med: Strengths and Limitations
Noom Med Limitations
Many users report declining engagement with the app over time while continuing to pay the subscription
Cancellation policies for the app subscription have historically drawn consumer complaints
Ro: Strengths and Limitations
Ro Strengths
Prescribes FDA-approved brand-name GLP-1 medications, and its insurance concierge can check coverage for selected brand medications
Offers both semaglutide (Wegovy) and tirzepatide (Zepbound)
Broader health platform allows consolidation of multiple prescriptions through one provider
Ro Limitations
Membership and medication are billed separately, and the medication price depends on product, dose and offer terms
Confirm current coaching and lifestyle-support options with Ro
The Bottom Line: Which Provider Should You Choose?
Compounded medications are not FDA-approved.
If you are currently on Noom Med or Ro and considering a switch, our step-by-step guides walk you through the process: how to cancel Noom Med and switch providers and how to cancel Ro and switch providers.
Frequently Asked Questions
Is Noom Med or Ro cheaper for semaglutide?
Compare each provider's full monthly total at your prescribed dose; see our Ro pricing guide at trytrimi.com/blog/ro-pricing-for-weight-loss for current Ro membership and medication charges.
Does Noom Med include the Noom app?
Patients should verify current pricing and what is included before enrolling.
Can I get tirzepatide through Noom Med or Ro?
For patients specifically seeking tirzepatide, verify current availability directly with each provider, as medication offerings evolve.
Is Noom's behavioral coaching worth the extra cost?
The value of Noom's behavioral coaching depends on your individual needs. Clinical research supports combining behavioral therapy with GLP-1 medication for weight loss. However, the Noom app's coaching is delivered through an algorithm-driven platform rather than one-on-one sessions with a specialist. Many patients find that the GLP-1 medication itself significantly reduces the behavioral challenges around eating, making intensive coaching less necessary than it would be without medication. Patients who are self-motivated or already knowledgeable about nutrition may not find the additional $32 to $70 per month worthwhile.
Can I switch from Noom Med or Ro to Trimi?
Complete Trimi's online health assessment and share your current medication and dose, and a Trimi provider will evaluate whether compounded semaglutide or tirzepatide is appropriate for you. Ro patients on brand-name Wegovy or Zepbound would be moving to a compounded preparation, which is not FDA-approved. See our guides on switching from Noom Med and switching from Ro for step-by-step instructions.
Sources & References
- Wilding JPH, et al. "Once-Weekly Semaglutide in Adults with Overweight or Obesity." New England Journal of Medicine, 2021;384(11):989-1002 (STEP 1 trial).
- Jastreboff AM, et al. "Tirzepatide Once Weekly for the Treatment of Obesity." New England Journal of Medicine, 2022;387(3):205-216 (SURMOUNT-1 trial).
- Wadden TA, et al. "Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy on Body Weight in Adults with Overweight or Obesity: The STEP 3 Randomized Clinical Trial." JAMA, 2021;325(14):1403-1413.
- Noom Med. Official pricing and program information. 2026.
- Ro Health. Official pricing and program information. 2026.
- FDA guidance on compounding and the FDA: questions and answers.
Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting any medication or treatment program. Pricing and availability information is approximate and subject to change, verify current rates directly with each provider. Trimi is a competing provider; this comparison is presented fairly but readers should verify current pricing and program details independently.